Log in

NASDAQ:OCULOcular Therapeutix Earnings Date, Estimates & History

+0.02 (+0.42 %)
(As of 04/6/2020 07:49 AM ET)
Today's Range
Now: $4.78
50-Day Range
MA: $5.20
52-Week Range
Now: $4.78
Volume368,167 shs
Average Volume1.17 million shs
Market Capitalization$251.33 million
P/E RatioN/A
Dividend YieldN/A


Ocular Therapeutix (NASDAQ:OCUL) Earnings Information

Ocular Therapeutix last issued its earnings results on March 12th, 2020. The biopharmaceutical company reported ($0.53) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.45) by $0.08. The firm earned $2.26 million during the quarter, compared to analyst estimates of $2.30 million. Ocular Therapeutix has generated ($2.01) earnings per share over the last year. Ocular Therapeutix has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, May 8th, 2020 based off prior year's report dates.

Ocular Therapeutix Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Ocular Therapeutix (NASDAQ:OCUL) Earnings Estimates

2020 EPS Consensus Estimate: ($0.88)
2021 EPS Consensus Estimate: ($0.28)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20202($0.39)($0.29)($0.34)
Q2 20203($0.27)($0.25)($0.26)
Q3 20203($0.18)($0.16)($0.17)
Q4 20203($0.17)($0.07)($0.11)
Q1 20212($0.08)($0.07)($0.08)
Q2 20212($0.07)($0.06)($0.07)
Q3 20212($0.07)($0.06)($0.07)
Q4 20211($0.07)($0.07)($0.07)

Ocular Therapeutix (NASDAQ OCUL) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
3/12/202012/31/2019($0.45)($0.53)($0.41)$2.30 million$2.26 millionTranscript
11/12/20199/30/2019($0.46)($0.45)($0.45)$1.09 million$0.83 millionTranscript
8/7/2019Q2 2019($0.42)($0.57)($0.57)$1.00 million$0.65 millionN/A
5/10/20193/31/2019($0.42)($0.45)($0.45)$0.45 million$0.49 millionN/A
3/7/201912/31/2018($0.37)($0.42)($0.42)$0.45 million$0.50 millionTranscript
11/7/20189/30/2018($0.36)($0.38)($0.38)$0.45 million$0.50 millionN/A
8/7/2018Q2 2018($0.37)($0.37)($0.37)$0.35 million$0.65 millionN/A
5/8/2018Q1 2018($0.38)($0.40)($0.40)$0.34 millionN/A
3/8/2018Q4 2017($0.58)($0.44)($0.44)$0.51 million$0.50 millionN/A
11/7/2017Q3 2017($0.54)($0.54)($0.54)$0.52 million$523.00 millionN/A
8/8/2017Q2 2017($0.59)($0.64)($0.64)$0.51 million$0.40 millionListen
5/5/2017Q1 2017($0.4830)($0.58)($0.58)$0.51 million$0.48 millionN/A
3/10/2017Q4 2016($0.47)($0.52)($0.52)$0.48 million$0.51 millionN/A
11/9/2016Q3 2016($0.39)($0.39)$0.47 million$0.48 millionListen
8/9/2016Q2 2016($0.49)($0.46)($0.46)$0.55 million$0.44 millionListen
5/10/2016Q1 2016($0.45)($0.44)($0.44)$458.00 millionListen
3/10/2016Q4 2015($0.46)($0.43)($0.43)$0.44 millionListen
11/10/2015Q3 2015($0.47)($0.47)$0.43 millionListen
8/10/2015Q2 2015($0.45)($0.45)$0.46 millionListen
5/15/2015Q1 2015($0.35)($0.35)$0.30 million$0.43 millionListen
3/10/2015Q4 2014($0.40)($0.37)($0.37)$0.20 million$0.51 millionListen
11/12/2014Q3 2014($0.55)($0.48)($0.48)$0.10 million$0.14 millionListen
8/28/2014Q2 2014($2.31)($2.10)($2.10)$0.10 million$0.10 millionN/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 4/6/2020 by MarketBeat.com Staff

Featured Article: Reverse Stock Split

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel